Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Malliga, DE; Wagner, D; Fahrleitner-Pammer, A.
The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review.
Wien Med Wochenschr. 2011; 161(23-24):565-570
Doi: 10.1007/s10354-011-0022-7
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Fahrleitner-Pammer Astrid
- Malliga Daniela-Eugenia
- Co-Autor*innen der Med Uni Graz
- Wagner Doris
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Initially described as key regulators in metabolic bone disease osteoprotegerin (OPG), receptor activator of nuclear factor kappa B (RANK) and RANK ligand (RANKL) have also been discriminated as regulators in immunologic function. Cardiovascular diseases (CVD) develop over many years in life and are often triggered by inflammatory processes within the vessel wall that lead to vascular remodeling. Recently some study groups have described OPG as a prognostic parameter for mortality and morbidity in cardiovascular patients.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Age Factors -
- Aged -
- Arteriosclerosis - physiopathology
- Bone Density - physiology
- Bone Resorption - physiopathology
- Cardiovascular Diseases - physiopathology
- Coronary Disease - physiopathology
- Female -
- Gonadal Steroid Hormones - blood
- Heart Failure - physiopathology
- Humans -
- Male -
- Middle Aged -
- Osteoclasts - physiology
- Osteoporosis - physiopathology
- Osteoprotegerin -
- Prognosis -
- RANK Ligand -
- Receptor Activator of Nuclear Factor-kappa B -
- Sex Factors -
- Ventricular Dysfunction, Left - physiopathology
- Young Adult -